RPTX – repare therapeutics inc. - common shares (US:NASDAQ)
Stock Stats
News
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib [Yahoo! Finance]
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
Repare Therapeutics Inc. (NASDAQ: RPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
Form 424B5 Repare Therapeutics Inc.
Form 10-Q Repare Therapeutics Inc. For: Sep 30
Form 8-K Repare Therapeutics Inc. For: Nov 07
Form 8-K Repare Therapeutics Inc. For: Aug 01
Form EFFECT Repare Therapeutics Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.